OncoImmunology
Volume 9, 2020 - Issue 1
Brief Report
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
Edda Blümela LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
https://orcid.org/0000-0002-3270-9466View further author information
https://orcid.org/0000-0002-3270-9466View further author information, Shamaila Munir Ahmadb Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmarkhttps://orcid.org/0000-0001-5176-5212View further author information
https://orcid.org/0000-0001-5176-5212View further author information, Claudia Nastasia LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0003-4438-0554View further author information
https://orcid.org/0000-0003-4438-0554View further author information, Andreas Willerslev-Olsena LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0001-9687-7269View further author information
https://orcid.org/0000-0001-9687-7269View further author information, Maria Gluuda LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0001-8877-3486View further author information
https://orcid.org/0000-0001-8877-3486View further author information, Simon Fredholma LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0002-8870-949XView further author information
https://orcid.org/0000-0002-8870-949XView further author information, Tengpeng Hua LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0001-8049-2743View further author information
https://orcid.org/0000-0001-8049-2743View further author information, Bas G. J. Surewaardc Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canadahttps://orcid.org/0000-0001-6367-3235View further author information
https://orcid.org/0000-0001-6367-3235View further author information, Lise M. Lindahld Department of Dermatology, Aarhus University Hospital, Aarhus, Denmarkhttps://orcid.org/0000-0003-3768-4146View further author information
https://orcid.org/0000-0003-3768-4146View further author information, , Sergei B. Koralovf Department of Pathology, New York University School of Medicine, New York, USAhttps://orcid.org/0000-0002-4843-3791View further author information
https://orcid.org/0000-0002-4843-3791View further author information, , , , Thorbjørn Krejsgaarda LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0001-6350-1150View further author information
https://orcid.org/0000-0001-6350-1150View further author information, Charlotte Menné Bonefelda LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0002-0523-6229View further author information
https://orcid.org/0000-0002-0523-6229View further author information, Carsten Geislera LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0002-8472-0771View further author information
https://orcid.org/0000-0002-8472-0771View further author information, Jürgen C. Beckeri Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen and Deutsches Krebsforschungszentrum (DKFZ), Essen, Germanyhttps://orcid.org/0000-0001-9183-653XView further author information
https://orcid.org/0000-0001-9183-653XView further author information, Anders Woetmanna LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0002-3008-735XView further author information
https://orcid.org/0000-0002-3008-735XView further author information, Mads Hald Andersenb Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmarkhttps://orcid.org/0000-0002-2914-9605View further author information
https://orcid.org/0000-0002-2914-9605View further author information, Terkild Brink Buusa LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0001-7180-6384View further author information
https://orcid.org/0000-0001-7180-6384View further author information & show all